Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [765]
News [2192]
Articles [90]
Editorials [3]
Conferences [62]
elearning [19]
Updated data from the Phase 1/2 MajesTEC-1 study evaluating teclistamab, a BCMA...
Dr Ajay Nooka - Winship Cancer Institute of Emory University, Georgia, USA
Updated data from the Phase 1/2 MajesTEC-1 study evaluating teclistamab, a BCMA x CD3 bispecific antibody ( Dr Ajay Nooka - Winship Cancer Institute of Emory University, Georgia, USA )
6 Jun 2022
ASCO 2022: Latest in EGFR positive NSCLC
Prof Benjamin Besse, Dr Anna Minchom, Dr Antonio Passaro and Dr Enriqueta Felip
ASCO 2022: Latest in EGFR positive NSCLC ( Prof Benjamin Besse, Dr Anna Minchom, Dr Antonio Passaro and Dr Enriqueta Felip )
5 Jun 2022
Latest in testing and diagnostics in exon 20 NSCLC
Dr Antonio Passaro and Prof Paul Hofman
Latest in testing and diagnostics in exon 20 NSCLC ( Dr Antonio Passaro and Prof Paul Hofman )
4 Jun 2022
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC
Dr Roy Herbst - Yale Cancer Center, New Haven, USA
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
4 Jun 2022
Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2...
Dr Grace Dy - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Long-term outcomes with sotorasib in pretreated KRASp.G12C-mutated NSCLC: 2-year analysis of CodeBreaK100 ( Dr Grace Dy - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
10 May 2022
Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for...
Prof Nicolas Girard - Institut Curie, Paris, France
Nivolumab plus platinum-doublet chemo vs chemo as neoadjuvant treatment for resectable NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )
10 May 2022
Recent advances in the treatment of patients with exon 20 insertion-positive...
Dr Alfredo Addeo, Prof Nicolas Girard and Prof Natasha Leighl
Recent advances in the treatment of patients with exon 20 insertion-positive NSCLC ( Dr Alfredo Addeo, Prof Nicolas Girard and Prof Natasha Leighl )
21 Apr 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )
14 Apr 2022
Immune gene signatures for predicting response to neoadjuvant...
Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda...
Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC ( Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
31 Mar 2022
Real-world increase in biomarker testing in lung cancer
Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda...
Real-world increase in biomarker testing in lung cancer ( Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
30 Mar 2022
EGFR testing: Best practice for NSCLC patients with exon 20 insertions
Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari
EGFR testing: Best practice for NSCLC patients with exon 20 insertions ( Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari )
30 Mar 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Feb 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation